000			01985 a2200553 4500
005			20250517023533.0
264		0	_c20160218
008			201602s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0121072 _2doi
040			_aNLM _beng _cNLM
100	1		_aSmith, Gaynor A
245	0	0	_aA Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C). _h[electronic resource]
260			_bPloS one _c2015
300			_ae0121072 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine _xbiosynthesis
650	0	4	_aDopaminergic Neurons _xmetabolism
650	0	4	_aGene Expression
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aInflammation _xchemically induced
650	0	4	_aMale
650	0	4	_aMicroglia _xmetabolism
650	0	4	_aNerve Degeneration _xdrug therapy
650	0	4	_aNeuroprotection _xdrug effects
650	0	4	_aNuclear Receptor Subfamily 4, Group A, Member 2 _xagonists
650	0	4	_aOxidopamine _xtoxicity
650	0	4	_aParkinson Disease, Secondary _xdrug therapy
650	0	4	_aPars Compacta _xdrug effects
650	0	4	_aPoly I-C _xadministration & dosage
650	0	4	_aPyridines _xadministration & dosage
650	0	4	_aRNA, Double-Stranded
650	0	4	_aRats
650	0	4	_aToll-Like Receptor 3 _xbiosynthesis
700	1		_aRocha, Emily M
700	1		_aRooney, Thomas
700	1		_aBarneoud, Pascal
700	1		_aMcLean, Jesse R
700	1		_aBeagan, Jonathan
700	1		_aOsborn, Teresia
700	1		_aCoimbra, Madeleine
700	1		_aLuo, Yongyi
700	1		_aHallett, Penelope J
700	1		_aIsacson, Ole
773	0		_tPloS one _gvol. 10 _gno. 3 _gp. e0121072
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0121072 _zAvailable from publisher's website
999			_c24748440 _d24748440